Literature DB >> 25879356

Protective effect of infliximab on methotrexate-induced liver injury in rats: unexpected drug interaction.

Erkan Cure1, Aynur Kirbas, Levent Tumkaya, Medine Cumhur Cure, Yildiray Kalkan, Arif Yilmaz, Suleyman Yuce.   

Abstract

AIMS: Although methotrexate (mtx) is a widely used agent to treat cancer and inflammatory diseases, its hepatotoxic effect limits for clinical utility. We aimed to investigate whether infliximab (inf), an inhibitor of tumor necrosis factor-alpha (TNF-α) has a protective effect against mtx-induced hepatotoxicity.
MATERIALS AND METHODS: For mtx group, the animals received an intraperitoneal single dose injection of mtx at a dose of 20 mg/kg. For inf group, the animals received an intraperitoneal single dose injection of inf at a dose of 7 mg/kg. For mtx + inf group, the single dose of inf at a dose of 7 mg/kg was given 72 h prior to mtx injection. After 72 h, a single dose of mtx 20 mg/kg was given. All rats were sacrificed 5 days after mtx injection.
RESULTS: TNF-α and nitric oxide (NO) levels of mtx group was significantly higher than the control (P < 0.001), inf (P < 0.001) and mtx + inf (P < 0.001) groups. Total score of histological damage was higher in the mtx group when compared with the mtx + inf group. Arginase and carbamoyl phosphate synthetase 1 (CPS-1) of mtx group was suppressed in comparison with the control group and was markedly increased in mtx + inf group.
CONCLUSION: Inf may partially prevent mtx-induced hepatic damage in rats. However, the combined usage of mtx and inf increases arginase and CPS-1 enzyme activities and at the same time blocks TNF-α. This combination especially in cancer patients may lead to cancer cell invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25879356     DOI: 10.4103/0973-1482.140809

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  6 in total

1.  Infliximab Modulates Cisplatin-Induced Hepatotoxicity in Rats.

Authors:  Medine Cumhur Cüre; Erkan Cüre; Yıldıray Kalkan; Aynur Kırbaş; Levent Tümkaya; Arif Yılmaz; Ayşegül Küçükali Türkyılmaz; İbrahim Şehitoğlu; Süleyman Yüce
Journal:  Balkan Med J       Date:  2016-09-01       Impact factor: 2.021

2.  Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats.

Authors:  Aly M Abdelrahman; Yousuf M Al Suleimani; Priyadarsini Manoj; Mohammed Ashique; Badreldin H Ali; Nicole Schupp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-09       Impact factor: 3.000

Review 3.  New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants.

Authors:  Mauro Cataldi; Vincenzo Citro; Chiara Resnati; Federica Manco; Giovanni Tarantino
Journal:  Adv Ther       Date:  2021-03-24       Impact factor: 3.845

4.  The protective effect of infliximab against carbon tetrachloride-induced acute lung injury.

Authors:  Aysel Kurt; Levent Tumkaya; Suleyman Yuce; Hasan Turut; Medine Cumhur Cure; Ibrahim Sehitoglu; Yildiray Kalkan; Gokhan Pusuroglu; Erkan Cure
Journal:  Iran J Basic Med Sci       Date:  2016-06       Impact factor: 2.699

5.  Cytoprotective effects of molsidomine against methotrexate-induced hepatotoxicity: an experimental rat study.

Authors:  Emine Turkmen Samdanci; Mustafa Huz; Onural Ozhan; Kevser Tanbek; Esra Pamukcu; Ayse Nur Akatli; Hakan Parlakpinar
Journal:  Drug Des Devel Ther       Date:  2018-12-20       Impact factor: 4.162

6.  Antifibrotic preventive effect of polyethylene glycol (PEG) 3350 in methotrexateinduced hepatoxicity model.

Authors:  Hüseyin Acar; Omay Sorgun; Güner Yurtseve; Ejder Saylav Bora; Oytun Erbaş
Journal:  Acta Cir Bras       Date:  2022-07-22       Impact factor: 1.564

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.